BCG Revaccination Does Not Protect Against Leprosy in the Brazilian Amazon: A Cluster Randomised Trial
2008

BCG Revaccination and Leprosy Protection in Brazil

Sample size: 99770 publication Evidence: low

Author Information

Author(s): Cunha Sérgio S., Alexander Neal, Barreto Mauricio L., Pereira Emilia S., Dourado Inês, de Fátima Maroja Maria, Ichihara Yury, Brito Silvana, Pereira Susan, Rodrigues Laura C.

Primary Institution: Instituto de Saúde Coletiva, Universidade Federal da Bahia

Hypothesis

BCG revaccination would cause a 50% reduction in leprosy incidence.

Conclusion

The study found no evidence that a second dose of BCG vaccination protects schoolchildren against leprosy.

Supporting Evidence

  • The incidence rate ratio of leprosy in the intervention over the control arm was 0.99.
  • Results showed no significant difference in leprosy cases between vaccinated and unvaccinated children.
  • Follow-up lasted for 6 years and 8 months, involving nearly 100,000 children.

Takeaway

Giving kids a second shot of the BCG vaccine didn't help protect them from leprosy, just like the first shot.

Methodology

A cluster randomised community trial with 6 years and 8 months of follow-up involving schoolchildren aged 7-14 years.

Potential Biases

Potential bias due to the lack of blinding in diagnosis and the possibility of misdiagnosis.

Limitations

The study may have been affected by imbalances in baseline characteristics and the lack of blinding in diagnosis.

Participant Demographics

Schoolchildren aged 7-14 years, with a total of 99,770 participants.

Statistical Information

Confidence Interval

0.68 to 1.45

Statistical Significance

p>0.05

Digital Object Identifier (DOI)

10.1371/journal.pntd.0000167

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication